| Symbol | MDAIW |
|---|---|
| Name | SPECTRAL AI, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 2515 MCKINNEY AVENUE,SUITE 1000, DALLAS, Texas, 75201, United States |
| Telephone | +1 972 - 499-4934 |
| Fax | — |
| — | |
| Website | https://www.spectral-ai.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001833498 |
| Description | Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. It offers DeepView wound imaging solution, an AI technology and multispectral imaging system that provides healing assessments for burn wounds and diabetic foot ulcers. Spectral MD Holdings, Ltd. was incorporated in 2020 and is headquartered in Dallas, Texas. Additional info from NASDAQ: |
Director DiMaio John Michael 🟢 acquired 340.6K shares (4 derivative) of Spectral AI, Inc. (MDAI) at $1.84 Transaction Date: Aug 13, 2026 | Filing ID: 090782
Read more(30% Negative) SPECTRAL AI, INC. (MDAIW) Reports Q3 2026 Financial Results
Read moreSpectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
Read moreSpectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
Read moreSpectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
Read moreSpectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
Read moreDirector DiMaio John Michael 🟢 acquired 331.6K shares (4 derivative) of Spectral AI, Inc. (MDAI) at $1.84 Transaction Date: Jun 24, 2026 | Filing ID: 073099
Read more